C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations

Inflammation

Volumn 36, Issue 4, 2013, Pages 948-953

  Karadeniz, Gulistan ^a   Polat, Gulru ^a   Senol, Gunes ^b   Buyuksirin, Melih ^a  

^a Department of Chest Diseases   (Turkey)

^b Izmir Chest Diseases and Thoracic Surgery Hospital   (Turkey)

Author keywords

C reactive protein; chronic obstructive pulmonary disease; intensive care unit

Indexed keywords

C REACTIVE PROTEIN; HYPERTENSIVE FACTOR;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CARBON DIOXIDE TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CRITERION VARIABLE; CYANOSIS; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; OXYGEN TENSION; PERIPHERAL EDEMA; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; TRACHEOBRONCHITIS;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; LUNG; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 84880317481     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9625-z     Document Type: Article

References (32)

1. Global Initiative for Chronic Obstructive Lung Disease. 2004. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease. Updated 2004 http://www.goldcopd.com/uploads/users/files/ GOLDWkshp2004Clean.pdf.
2. Wedzicha, J.A.; and G.C. Donaldson. 2003. Exacerbations of chronic obstructive pulmonary disease. Respiratory Care 48: 1204-1213.
3. Reynolds, H.Y. 2004. Chronic obstructive pulmonary disease. In Principles and practice of infectious diseases, 6th ed, ed. G.L. Mandell, J.E. Bennett, and R. Dolin, 706-710. Philadelphia: Churchill Livingstone.
4. Johannes, M.A.D.; S. Marianne, S. Dominic, L.K. Dirk, L. René, and M.J. Henk. 2010. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest 138: 1108-1115.
5. Shameem, M.; R. Bhargava, and Z. Ahmad. 2011. Association between serum C-reactive protein levels and other important predictive markers of outcome in COPD. Acta Medica Iranica 49: 18-20.
6. TascI, C.; A. Balkan, N. Karadurmus, S. Inal, S. KIlIç, and M. Ozkan. 2008. The importance of serum procalcitonin levels in patients with chronic obstructive pulmonary disease exacerbations. Turkish Journal of Medical Sciences 38: 139-145.
7. Garcia-Rio, F.; M. Miravitlles, J.B. Soriano, L. Munoz, E.D. Tauleria, and G. Sanchez. 2010. Systemic inflammation in chronic obstructive pulmonary disease: A population-based study. Respiratory Research 11: 63-75.
8. Peisajovich, A.; L. Marnell, C. Mold, and T.W. Du Clos. 2008. C-reactive protein at the interface between innate immunity and inflammation. Expert Review of Clinical Immunology 4: 379-390.
9. Dinarello, C.A. 1996. The acute phase response. In Cecil textbook of medicine, 20th ed, ed. J.C. Bennett and F. Plum, 1535-1537. Philadelphia: WB Saunders.
10. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - Sixth edition: Approved standard M7-A6. NCCLS, Wayne.
11. Horan, T.C.; and R.P. Gaynes. 2004. Surveillance of nosocomial infections. In Hospital epidemiology and infection control, 3rd ed, ed. C.G. Mayhall, 1659-1702. Philadelphia: Lippincott Williams & Wilkins.
12. Erturk, E.; M. Polatl, A. Kocabaş, N. YIldIrIm, A. Gürgün, S. Saryal, and N. Kokturk. 2010. Consensus report of Turkish Thoracic Society for the diagnosis and treatment of chronic obstructive lung disease. Turkish Thoracic Journal 11(Suppl 1): S5-S63
13. Lacoma, A.; C. Prat, F. Andreo, L. Lores, J. Ruiz-Manzano, V. Ausina, and J. Domínguez. 2011. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 6: 157-169. doi: 10.2147/COPD.S16070.
14. Seppa, Y.; A. Bloigu, P.O. Honkanen, L. Miettine, and H. Syrjala. 2001. Severity assessment of lower respiratory tract infection in elderly patients in primary care. Archives of Internal Medicine 161: 2709-2713.
15. Almirall, J.; I. Bolibar, P. Toran, G. Pera, X. Boquet, X. Balanzó, et al. 2004. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 125: 1335-1342.
16. Lacoma, A.; C. Prat, F. Andreo, and J. Dominguez. 2009. Biomarkers in the management of COPD. European Respiratory Review 18: 96-104.
17. Dahl, M.; J. Vestbo, P. Lange, S.E. Bojesen, A. Tybjaerg-Hansen, and B.G. Nordestgaard. 2007. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 175: 250-255.
18. Gan, W.Q.; S.F.P. Man, A. Senthilselvan, and D.D. Sin. 2004. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and meta-analysis. Thorax 59: 574-580.
19. Tofan, F.; M.H. Rahimi-Rad, Y. Rasmi, and S. Rahimirad. 2012. High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease. Pneumologia 61: 160-162.
20. Zhang, Y.; H. Bunjhoo, W. Xiong, Y. Xu, and D. Yang. 2012. Association between C-reactive protein concentration and chronic obstructive pulmonary disease: A systematic review and meta-analysis. The Journal of International Medical Research 40: 1629-1635.
21. Mannino, D.M.; E.S. Ford, and S.C. Redd. 2003. Obstructive and restrictive lung disease and markers of inflammation: Data from the Third National Health and Nutrition Examination. American Journal of Medicine 114: 758-762.
22. Broekhuizen, R.; E.F.M. Wouters, E.C. Creutzberg, and A.M.W.J. Schols. 2006. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61: 17-22.
23. Stockley, R.A.; C. O'Brien, A. Pye, and S.L. Hill. 2000. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 117: 1638-1645.
24. Nural, S.; E. Gunay, B. Halici, S. Celik, and M. Unlu. 2013. Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 36: 66-74.
25. Yanbaeva, D.G.; M.A. Dentener, E.C. Creutzberg, G. Wesseling, and E.F. Wouters. 2007. Systemic effects of smoking. Chest 131: 1557-1566.
26. Pinto-Plata, V.M.; H. Mullerova, J.F. Toso, M. Feudjo-Tepie, J.B. Soriano, and R.S. Vessey. 2006. C-reactive protein in patients with COPD, control smokers and nonsmokers. Thorax 6: 23-28.
27. Gan, W.Q.; S.F. Paul Man, and D.D. Sin. 2005. The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest 127: 558-564.
28. Lowy, F.D. 1998. Staphylococcus aureus infections. The New England Journal of Medicine 339: 520-532.
29. Kadioglu, A.; and P.W. Andrew. 2004. The innate immune response to pneumococcal lung infection: The untold story. Trends in Immunology 25: 143-149.
30. Sethi, S.; C. Wrona, K. Eschberger, P. Lobbins, X. Cai, and T.F. Murphy. 2008. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 177: 491-497.
31. Murphy, T.F. 2006. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Current Opinion in Infectious Diseases 19: 225-230.
32. Peng, C.; C. Tian, Y. Zhang, X. Yang, H. Fan, and Y. Feng. 2013. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease. The American Journal of the Medical Sciences 345: 190-194.